Literature DB >> 20229160

[Revascularization of coronary artery disease in diabetes mellitus].

Paul Wexberg1, Franz Weidinger.   

Abstract

Coronary artery disease in diabetes mellitus (DM) is still associated with a poor prognosis. Especially percutaneous coronary interventions (PCI) have a higher rate of complications and restenosis, so that surgical revascularization is usually favoured in DM. The development of drug-eluting stents has improved the results of PCI significantly, however, there are still not enough prospective data comparing them to bypass surgery. The present paper summarizes the current state of coronary revascularization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229160     DOI: 10.1007/s10354-010-0746-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  23 in total

1.  Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.

Authors:  Y T Kruszynska; J G Yu; J M Olefsky; B E Sobel
Journal:  Diabetes       Date:  2000-04       Impact factor: 9.461

2.  New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study.

Authors:  F Ledru; P Ducimetière; S Battaglia; D Courbon; F Beverelli; L Guize; J L Guermonprez; B Diébold
Journal:  J Am Coll Cardiol       Date:  2001-05       Impact factor: 24.094

Review 3.  Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes.

Authors:  Marco Roffi; Eric J Topol
Journal:  Eur Heart J       Date:  2004-02       Impact factor: 29.983

4.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

5.  Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.

Authors:  David R Holmes; Martin B Leon; Jeffrey W Moses; Jeffrey J Popma; Donald Cutlip; Peter J Fitzgerald; Charles Brown; Tim Fischell; Shing Chiu Wong; Mark Midei; David Snead; Richard E Kuntz
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

6.  Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients.

Authors:  Christoph Schukro; Bonni Syeda; Nabil Yahya; Alois Gessl; Erik W Holy; Philipp Pichler; Michael Derntl; Dietmar Glogar
Journal:  J Diabetes Complications       Date:  2007 Nov-Dec       Impact factor: 2.852

7.  Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention.

Authors:  Roberto A Corpus; Peter B George; John A House; Simon R Dixon; Steven C Ajluni; William H Devlin; Gerald C Timmis; Mamtha Balasubramaniam; William W O'Neill
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

8.  Type 2 diabetes is associated with more advanced coronary atherosclerosis on multislice computed tomography and virtual histology intravascular ultrasound.

Authors:  Gabija Pundziute; Joanne D Schuijf; J Wouter Jukema; Jacob M van Werkhoven; Gaetano Nucifora; Isabel Decramer; Giovanna Sarno; Piet K Vanhoenacker; Johannes H C Reiber; William Wijns; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2009-05-13       Impact factor: 5.952

9.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

10.  Mechanism of lumen gain during coronary stent deployment in diabetic patients compared with non-diabetic patients.

Authors:  Bonni Syeda; Paul Wexberg; Mariann Gyongyosi; Stefan Denk; Gilbert Beran; Wolfgang Sperker; Nabil Yahya; Dietmar Glogar
Journal:  Coron Artery Dis       Date:  2002-08       Impact factor: 1.439

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.